Cyclacel Pharma (CYCC) Tops Q4 EPS by 6c
Tweet
Share
E-mailGet Alerts CYCC Hot Sheet
Price: $6.37 --0%
Financial Fact:
Research and development: 2.41M
Today's EPS Names:
OFLX, NMRD, VAXX, More
Financial Fact:
Research and development: 2.41M
Today's EPS Names:
OFLX, NMRD, VAXX, More
Join SI Premium – FREE
Cyclacel Pharma (NASDAQ: CYCC) reported Q4 EPS of ($0.20), $0.06 better than the analyst estimate of ($0.26). Revenue for the quarter came in at $299 thousand, versus $247 thousand reported last year.
Cyclacel reported Q413 loss of $0.21 per share.
For earnings history and earnings-related data on Cyclacel Pharma (CYCC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance
- Xos, Inc (XOS) Tops Q2 EPS by 5c
- Faraday Future Intelligent Electric Inc. (FFAI) Tops Q2 EPS by $20.87, Misses on Revenue
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
